These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38171827)
21. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607 [TBL] [Abstract][Full Text] [Related]
22. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352 [TBL] [Abstract][Full Text] [Related]
23. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571 [TBL] [Abstract][Full Text] [Related]
24. Little A; Tangney M; Tunney MM; Buckley NE Expert Rev Mol Med; 2023 Apr; 25():e15. PubMed ID: 37009688 [TBL] [Abstract][Full Text] [Related]
25. More Than Just a Periodontal Pathogen -the Research Progress on Chen Y; Huang Z; Tang Z; Huang Y; Huang M; Liu H; Ziebolz D; Schmalz G; Jia B; Zhao J Front Cell Infect Microbiol; 2022; 12():815318. PubMed ID: 35186795 [No Abstract] [Full Text] [Related]
26. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553 [TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of Zhang N; Liu Y; Yang H; Liang M; Wang X; Wang M; Kong J; Yuan X; Zhou F Pathol Oncol Res; 2021; 27():1609846. PubMed ID: 34305476 [TBL] [Abstract][Full Text] [Related]
28. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection. Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893 [TBL] [Abstract][Full Text] [Related]
29. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934 [TBL] [Abstract][Full Text] [Related]
30. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Wang N; Fang JY Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786 [TBL] [Abstract][Full Text] [Related]
31. Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins. Zanzoni A; Spinelli L; Braham S; Brun C Microbiome; 2017 Aug; 5(1):89. PubMed ID: 28793925 [TBL] [Abstract][Full Text] [Related]
32. Involvement of He Z; Tian W; Wei Q; Xu J Front Immunol; 2022; 13():968649. PubMed ID: 36059542 [No Abstract] [Full Text] [Related]
33. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis. Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323 [TBL] [Abstract][Full Text] [Related]
34. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Fardini Y; Wang X; Témoin S; Nithianantham S; Lee D; Shoham M; Han YW Mol Microbiol; 2011 Dec; 82(6):1468-80. PubMed ID: 22040113 [TBL] [Abstract][Full Text] [Related]
37. Study of the inflammatory activating process in the early stage of Fusobacterium nucleatum infected PDLSCs. Wang Y; Wang L; Sun T; Shen S; Li Z; Ma X; Gu X; Zhang X; Peng A; Xu X; Feng Q Int J Oral Sci; 2023 Feb; 15(1):8. PubMed ID: 36754953 [TBL] [Abstract][Full Text] [Related]
38. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer. Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471 [TBL] [Abstract][Full Text] [Related]
39. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Rubinstein MR; Wang X; Liu W; Hao Y; Cai G; Han YW Cell Host Microbe; 2013 Aug; 14(2):195-206. PubMed ID: 23954158 [TBL] [Abstract][Full Text] [Related]
40. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]